

A provider's guide to helping patients afford Tobradex. Learn about generics, savings cards, PAPs, and how to build cost conversations into your workflow.
You prescribe Tobradex (Tobramycin/Dexamethasone) because it works. It's a proven combination for bacterial ocular infections with an inflammatory component, and it's been a go-to in ophthalmology and optometry practices for decades. But when your patient gets to the pharmacy and sees a $200–$350 cash price, adherence becomes a real concern.
Studies consistently show that medication cost is one of the top reasons patients don't fill their prescriptions — or stretch doses to make a bottle last longer. For a time-sensitive eye infection, either behavior can lead to treatment failure, prolonged symptoms, or complications.
This guide covers practical strategies you can implement to help patients access Tobradex affordably — from generic substitution to manufacturer programs, discount cards, and patient assistance for the uninsured.
Here's the current cost landscape for Tobradex:
Insurance coverage varies significantly. Most plans cover the generic with copays of $10–$30. Brand-name Tobradex is often on a higher formulary tier or may require prior authorization when a generic is available. Some plans implement step therapy requiring a trial of the generic first.
For uninsured patients or those with high-deductible plans, the brand-name price is prohibitive for what is typically a 5–14 day treatment course.
The single most impactful step you can take is prescribing or allowing generic substitution.
Generic Tobramycin/Dexamethasone ophthalmic suspension is widely available and contains the same active ingredients at the same concentrations as brand-name Tobradex. At $28–$55 with a discount card, it's a fraction of the brand price.
Unless there's a specific clinical reason for brand-name Tobradex (rare), writing your prescription to allow generic substitution — or explicitly prescribing the generic — removes a major cost barrier.
If Tobradex or its generic isn't available or affordable, consider these therapeutic alternatives:
For a detailed clinical comparison, see our overview of Tobradex alternatives.
For patients who need brand-name Tobradex, manufacturer programs can significantly reduce out-of-pocket costs:
Novartis offers a co-pay savings card for commercially insured patients. Eligible patients can reduce their copay on brand-name Tobradex. Details and enrollment are available at copay.novartispharma.com.
Key details:
Since Tobradex is distributed by Alcon, patients can also explore Alcon's payment assistance programs at myalcon.com/payment-assistance-programs/.
For uninsured, low-income patients, the Novartis Patient Assistance Foundation (PAF) provides qualifying medications at no cost. Patients can apply through:
Eligibility typically requires proof of income below a certain threshold and lack of prescription drug coverage. Processing times vary, so this may not help for acute prescriptions needed immediately — but it's valuable for patients with chronic or recurring conditions.
For patients paying cash or with high copays, free prescription discount cards can deliver significant savings on generic Tobramycin/Dexamethasone:
These cards work at the pharmacy counter — the patient simply presents the card or coupon code alongside their prescription. They're especially useful for:
You can proactively mention these resources during the visit. Many patients don't know they exist.
The most effective cost intervention is bringing up the topic before the patient reaches the pharmacy. Here are practical ways to integrate cost awareness into your prescribing workflow:
Make generic Tobramycin/Dexamethasone your default prescribing choice. Write "Tobramycin/Dexamethasone ophthalmic suspension" rather than "Tobradex" to ensure the pharmacy fills with the generic. Only specify brand-name when there's a clinical need.
A quick question — "Do you have prescription coverage? Are medication costs ever a concern?" — can surface barriers before they become non-adherence. Patients often don't volunteer this information.
Consider creating a simple handout or having staff share links to savings resources:
If your EHR has formulary checking capabilities, use them. Knowing whether a patient's plan covers generic Tobramycin/Dexamethasone — and at what tier — helps you avoid prescribing something the patient can't afford.
Occasionally, generic Tobramycin/Dexamethasone may have spotty availability at certain pharmacies. When availability is a concern, direct patients to Medfinder for Providers or have them check pharmacy stock before making the trip.
Noting cost conversations in the chart demonstrates patient-centered care and provides context if the patient returns reporting non-adherence.
Patients prescribed Tobradex after cataract surgery or other eye procedures are often dealing with multiple post-op medications simultaneously. The cumulative cost of several eye drops can be substantial. For these patients:
For patients with chronic conditions requiring intermittent Tobradex courses, the Novartis Patient Assistance Foundation may be particularly valuable. Help them apply during a non-urgent visit so coverage is in place for future needs.
Medication cost shouldn't determine whether your patient completes a course of Tobradex for a bacterial eye infection. By defaulting to generic prescribing, proactively discussing cost, and connecting patients with savings programs, you can significantly improve adherence and outcomes.
The tools exist — manufacturer savings cards, discount platforms, patient assistance foundations, and generic alternatives. The key is building awareness of these resources into your clinical workflow so cost conversations happen before the patient reaches the pharmacy counter.
For more provider resources, visit Medfinder for Providers. You can also explore our provider guides on helping patients find Tobradex in stock and our clinical overview of the Tobradex supply landscape in 2026.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.